LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis
Authors:
- Takahiro NakamuraTNTakahiro Nakamura
- Junji HamuroJHJunji Hamuro
- Mikiro TakaishiMTMikiro Takaishi
- Szandor SimmonsSSSzandor Simmons
- Kazuichi MaruyamaKMKazuichi Maruyama
- Andrea ZaffalonAZAndrea Zaffalon
- Adam J. BentleyABAdam J. Bentley
- Satoshi KawasakiSKSatoshi Kawasaki
- Maho Nagata-TakaokaMNMaho Nagata-Takaoka
- Nigel J. FullwoodNFNigel J. Fullwood
- Satoshi ItamiSISatoshi Itami
- Shigetoshi SanoSSShigetoshi Sano
Open Access
- 9 December 2013
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 124 (1) , 385-397
Abstract
Corneal integrity and transparency are indispensable for good vision. Cornea homeostasis is entirely dependent upon corneal stem cells, which are required for complex wound-healing processes that restore corneal integrity following epithelial damage. Here, we found that leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is highly expressed in the human holoclone-type corneal epithelial stem cell population and sporadically expressed in the basal cells of ocular-surface epithelium. In murine models, LRIG1 regulated corneal epithelial cell fate during wound repair. Deletion of Lrig1 resulted in impaired stem cell recruitment following injury and promoted a cell-fate switch from transparent epithelium to keratinized skin-like epidermis, which led to corneal blindness. In addition, we determined that LRIG1 is a negative regulator of the STAT3-dependent inflammatory pathway. Inhibition of STAT3 in corneas of Lrig1–/– mice rescued pathological phenotypes and prevented corneal opacity. Additionally, transgenic mice that expressed a constitutively active form of STAT3 in the corneal epithelium had abnormal features, including corneal plaques and neovascularization similar to that found in Lrig1–/– mice. Bone marrow chimera experiments indicated that LRIG1 also coordinates the function of bone marrow–derived inflammatory cells. Together, our data indicate that LRIG1 orchestrates corneal-tissue transparency and cell fate during repair, and identify LRIG1 as a key regulator of tissue homeostasis.Keywords
This publication has 50 references indexed in Scilit:
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signallingNature Cell Biology, 2012
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor SuppressorCell, 2012
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian EpidermisCell Stem Cell, 2009
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIIIOncogene, 2008
- LRIG1 Is a Novel Negative Regulator of the Met Receptor and Opposes Met and Her2 SynergyMolecular and Cellular Biology, 2007
- Epithelial Stem Cells: Turning over New LeavesCell, 2007
- Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescenceProceedings of the National Academy of Sciences, 2006
- Neural conversion of ES cells by an inductive activity on human amniotic membrane matrixProceedings of the National Academy of Sciences, 2006
- Three clonal types of keratinocyte with different capacities for multiplication.Proceedings of the National Academy of Sciences, 1987